Tel: +86 (0)571 8102-5280
Email: sales@molcore.com
Language :
English
中文版
日本語
Search
Home
About Us
CRO&CDMO
Services
Custom Synthesis
Process development
IP & Quality
Facility
R&D Center
Manufacturing
Products
Contact Us
Name Index L
Home
Sitemap
Name Index L
Recently searched keywords
4546-06-9
,
534572-28-6
,
86261-35-0
,
2098859-80-2
,
61786-58-1
,
1780189-93-6
,
217189-40-7
,
2891581-83-0
,
143028-36-8
,
2768445-58-3
,
1354702-16-1
,
2019165-20-7
,
600727-96-6
,
207569-15-1
,
20563-00-2
,
604798-84-7
,
60169-67-7
,
1699742-30-7
,
2341796-76-5
,
2743531-76-0
,
180623-99-8
,
317-79-3
,
49788-63-8
,
96734-46-2
,
10408-80-7
,
1995951-69-3
,
155789-98-3
,
1563033-70-4
,
69320-88-3
,
6154-39-8
,
685879-99-6
,
1053657-17-2
,
106245-03-8
,
1260589-81-8
,
2940937-98-2
,
1147110-58-4
,
23234-44-8
,
1258826-61-7
,
1190946-29-2
,
1211579-85-9
,
1211582-02-3
,
2607136-69-4
,
2755144-84-2
,
99849-75-9
,
1879653-39-0
,
1452829-44-5
,
2940861-09-4
,
2297626-49-2
,
2990097-57-7
,
2423908-44-3
,
2106156-11-8
,
135380-56-2
,
2302493-92-9
,
1260828-79-2
,
2926692-66-0
,
1889884-78-9
,
143359-81-3
,
2940940-67-8
,
1344418-08-1
,
650615-80-8
Products Sitemap
Cas Index
1
2
3
4
5
6
7
8
9
Name Index
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Name Index L
SKU
Chemical Name
Molecular Formula
MC826915
1119226-97-9 | Lercanidipine Acid
MC826914
74936-74-6 | 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid 1-methylpropyl ester
C19H22N2O6
MC826911
1198299-50-1 | dimethyl 2-(4-amino-1-oxoisoindolin-2-yl)pentanedioate
C15H18N2O5
MC826909
874760-69-7 | 5-amino-4-(4-amino-1-oxoisoindolin-2-yl)-5-oxopentanoic acid
C13H15N3O4
MC826904
1246819-06-6 | Lansoprazole Thioxo Impurity
MC826903
142384-07-4 | Lansoprazole 4-Nitro Analog
MC826898
136565-76-9 | Lamotrigine N2-Oxide
MC826897
38943-76-9 | Lamotrigine EP Impurity G
MC826896
661463-79-2 | Lamotrigine EP Impurity D
MC826895
136846-20-3 | Lamivudine 2-Epimer
MC826894
139757-68-9 | Lamivudine 5-Epimer
MC826893
173829-09-9 | Lamivudine EP Impurity A (Lamivudine Acid)
MC826891
388619-64-5 | N-Methyl Lacosamide
MC826890
171623-02-2 | Lacosamide Related Compound F
MC826886
32780-65-7 | Labetalol EP Impurity D
MC826885
2386661-13-6 | Labetalol EP Impurity C
MC826765
186694-45-1 | Licarbazepine Acetate R-Isomer
MC826676
38092-95-4 | Loratadine impurity A (Desloratadine Deschloro Impurity/ N-Desmethyl Azatadine)
MC826672
1798429-38-5 | 4[N’-[1-[3-Fluoro-4-methoxy-phenyl)-ethylidene]hydrazino}benzenesulfonamide
C15H16FN3O3S
MC826213
25967-34-4 | Loxapine-N-oxide
MC826212
860644-28-6 | Losartan IMpurity C
MC826211
1181690-72-1 | Lorcaserin EP Impurity C
MC826210
1361572-46-4 | Lorcaserin sulfate
MC826207
64936-81-8 | Lithocholic acid 3-sulfate disodium salt
MC826206
6140-11-0 | Linagliptin Impurity W
MC826205
668273-74-3 | Linagliptin Impurity X
MC826204
2138392-83-1 | Linaglipti Impurity B
MC826202
2055-97-2 | Levothyroxine EP Impurity H (Levothyroxine Benzoic Acid Impurity)
MC826201
102767-31-7 | Levetiracetam term RC-A(crude)
MC826200
957214-95-8 | Lercanidipine Dimethyl ester impurity oxalate salt
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
Next
© Copyright 2015-2024 Hangzhou MolCore BioPharmatech Co.,Ltd. All rights reserved.